These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis. Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532 [TBL] [Abstract][Full Text] [Related]
6. Qingkailing injection alleviates experimental autoimmune uveitis in rats via inhibiting Th1 and Th17 effector cells. Tian Q; Bi H; Cui Y; Guo D; Xie X; Su W; Wang X Biol Pharm Bull; 2012; 35(11):1991-6. PubMed ID: 23123470 [TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of the Interphotoreceptor Retinoid Binding ProteinInduced Models of Experimental Autoimmune Uveitis in B10.RIII versus C57BL/6 Mice. Chen Y; Chen Z; Chong WP; Wu S; Wang W; Zhou H; Chen J Curr Mol Med; 2018; 18(9):602-611. PubMed ID: 30636608 [TBL] [Abstract][Full Text] [Related]
8. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG. Castro BFM; Vieira LC; Vasconcelos-Santos DV; Cenachi SPF; Cotta OAL; Guerra MCA; Paiva MRB; Silva LM; Silva-Cunha A; Fialho SL Int Immunopharmacol; 2020 Apr; 81():106129. PubMed ID: 32018067 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model. Fan NW; Li J; Mittal SK; Foulsham W; Elbasiony E; Huckfeldt RM; Chauhan SK; Chen Y Am J Pathol; 2021 Mar; 191(3):425-437. PubMed ID: 32966818 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837 [TBL] [Abstract][Full Text] [Related]
13. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis. Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581 [TBL] [Abstract][Full Text] [Related]
14. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541 [TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Sakai T; Kohno H; Ishihara T; Higaki M; Saito S; Matsushima M; Mizushima Y; Kitahara K Exp Eye Res; 2006 Apr; 82(4):657-63. PubMed ID: 16360654 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses. Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321 [TBL] [Abstract][Full Text] [Related]
17. Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice. Meng X; Fang S; Zhang Z; Wang Y; You C; Zhang J; Yan H Cell Mol Immunol; 2017 Aug; 14(8):702-711. PubMed ID: 26996065 [TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats. Fagone P; Mangano K; Mammana S; Cavalli E; Di Marco R; Barcellona ML; Salvatorelli L; Magro G; Nicoletti F Clin Immunol; 2015 Apr; 157(2):198-204. PubMed ID: 25701800 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. Tang J; Zhu W; Silver PB; Su SB; Chan CC; Caspi RR J Immunol; 2007 May; 178(9):5578-87. PubMed ID: 17442940 [TBL] [Abstract][Full Text] [Related]
20. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]